Characteristics, management, and outcomes among admissions for primary cardiac tumors: Results from the National Inpatient Sample

Author(s):  
Joseph N. Heaton ◽  
Nehal Dhaduk ◽  
Alexis K. Okoh ◽  
Khoi P. Dang‐Ho ◽  
Rajiv Tayal ◽  
...  
Respiration ◽  
2021 ◽  
pp. 1-5
Author(s):  
Haizea Alvarez Martinez ◽  
Jolanda C. Kuijvenhoven ◽  
Jouke T. Annema

Primary cardiac tumors are extremely rare. Obtaining a tissue diagnosis is difficult and commonly requires open-heart surgery with associated morbidity. Esophageal endoscopic ultrasound (EUS) and EUS with the EBUS scope (EUS-B) provide real-time sampling of centrally located lung tumors and mediastinal lymph nodes. They also provide an excellent view of the left atrium, since it is located adjacent to the esophagus. To date, left atrium tumor diagnostics by endosonography is poorly explored. We describe 2 exceptional diagnostic cases of left atrium tumors in which cardiac surgery was hazardous due to the clinical condition or previous surgical interventions. During EUS-B-guided fine-needle aspiration (FNA), the left atrial masses were successfully and safely sampled, revealing a Burkitt lymphoma and a synovial sarcoma. FNA including cell block analysis enabled specific tumor diagnosis and molecular subtyping. Our findings suggest that in selected cases, linear endosonography qualifies as a minimally invasive technique for intracardiac tumor diagnostics.


CHEST Journal ◽  
2020 ◽  
Vol 158 (4) ◽  
pp. A93
Author(s):  
Joseph Zackary ◽  
Lauren Crowley ◽  
Shawn Quinn ◽  
Timothy Misselbeck

2016 ◽  
Vol 2016 ◽  
pp. 1-3 ◽  
Author(s):  
Marcos Danillo Peixoto Oliveira ◽  
Adriano Ossuna Tamazato ◽  
Fernando Roberto de Fazzio ◽  
Luiz J. Kajita ◽  
Expedito E. Ribeiro ◽  
...  

Primary cardiac tumors are rare and approximately half of them are atrial myxomas. They rarely remain asymptomatic, especially if large. The imaging of a myxoma by contrast dye during coronary angiography is an infrequent sign, which clarifies the vascular supply of the tumor. We report herein an interesting and rare case of a left atrial myxoma hypervascularized from the right coronary artery.


2018 ◽  
Vol 04 (04) ◽  
pp. e176-e181
Author(s):  
Khalil Jawad ◽  
Tamer Owais ◽  
Stefan Feder ◽  
Sven Lehmann ◽  
Martin Misfeld ◽  
...  

Objective The decision to operate cardiac tumors is an issue of balancing surgical outcome and survival with quality of life (QOL). We report our single-center experience in managing primary cardiac tumors between 1994 and 2014. Methods and Results In this study, 269 patients were subjected to our standardized operative protocols, preoperative preparations, postoperative follow-up, and consents of participation. Demographic and preoperative/intraoperative/postoperative variables were collected with focus on long-term follow-up and survival. A total of 72,000 cardiac procedures were performed within 20 years at our institution. Two hundred sixty-nine patients were diagnosed with primary cardiac tumors (0.37%), with a male:female ratio of 1:1.68, mean age of 57.4 ± 19.5 years, and body mass index of 25.49 ± 6.5. The most presenting symptoms were dyspnea (n = 94), arrhythmias (n = 53), embolic event (n = 36), and chest pain (n = 29), and 33 patients were accidentally discovered. Isolated tumor excision and concomitant ablation were performed on 181 patients, while the rest needed additional procedures such as coronary artery bypass grafting (n = 27) or valve surgery (n = 61). Focus on pathology, tumor location was done reporting the commonest pathology such as myxoma (n = 177) and fibroelastoma (n = 56). The frequent site was the left atrium (n = 162). Our primary results showed incidence of bleeding in 9 patients (3.3%), arrhythmias in 76 patients (28.25%), and mortality in 49 patients (18.2%). Five patients (1.8%) showed recurrence and 220 patients (81.8%) showed complaint-free survival. Conclusion Complete excision of primary cardiac tumors is the golden rule in management as it improves survival and decreases morbidity expected from the progressing tumors process. The progression of minimally invasive techniques improves QOL and should be performed whenever possible.


2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
K. Jawad ◽  
T.O. Owais ◽  
B.P. Pfannmueller ◽  
M.D. Dieterlein ◽  
S.L. Lehmann ◽  
...  

2021 ◽  
pp. 77-79
Author(s):  
Pradeep Kumar Radhakrishnan ◽  
Gayathri Ananyajyothi Ambat ◽  
Nihas Nazer ◽  
Sushamma Murugan ◽  
Arun Vijyakaumar ◽  
...  

Primary cardiac tumors are rare. The incidence varies between 0.3% to 0.7% .Quarter of all primary cardiac tumors are malignant, of these 75% are sarcomas. Malignant primary cardiac sarcomas that affect right atrium are predominantly angiosarcomas while the left atrium is involved primary in pleomorphic sarcoma like malignant brous histiocytoma and leiomyosarcoma. In a young patient it usually carries a dismal prognosis if not diagnosed early and dealt with surgically followed by adjuvant therapy. Without surgical resection, the survival rate at 1yr is only 10%.Retrospective evaluation of the last 60 primary cardiac tumors done by the same surgical team over 28 years was looked into.


Sign in / Sign up

Export Citation Format

Share Document